Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Е. В. Пономарева
Observed names:
E V Ponomareva,
E. Ponomareva,
E. V. Ponomareva,
E.V. Ponomareva,
Elena Ponomareva,
Ye. V. Ponomaryova
show all 6
Institution:
Mental Health Research Center of Russian Academy of Medical Sciences
Observed institutions:
City Clinical Oncology Center,
Mental Health Research Center of Russian Academy of Medical Sciences
ORCID:
0000-0002-2835-5706
Observed ORCID:
0000-0002-2835-5706
OpenAlex ID:
A5067334479
Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment
2018
·
S. I. Gavrilova
, I. V. Kolykhalov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
21
Anti-inflammatory effects of neurotrophic therapy (a pilot study)
2018
·
I. K. Malashenkova
, S. A. Krynskiy
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
14
Efficacy and safety of choline alfoscerate in the preventive therapy of dementia in elderly patients with Mild Cognitive Impairment: a three-year prospective comparative study
2024
·
E.V. Ponomareva
, L.V. Androsova
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
9
Therapeutic monitoring and prediction of the efficacy of neurotrophic treatment in patients with amnestic type of mild cognitive impairment
2017
·
S. I. Gavrilova
, O. M. Volpina
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
9
Levels of proinflammatory cytokines and vascular endothelial growth factor in patients with Alzheimer’s disease and mild cognitive impairment
2016
·
I.K. Malashenkova
, N.A. Hailov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
9
Prognosis of amnestic mild cognitive impairment: clinical and immunological correlations
2021
·
E.V. Ponomareva
, S.A. Krinsky
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
7
Levels of Proinflammatory Cytokines and Growth Factor VEGF in Patients with Alzheimer’s Disease and Mild Cognitive Impairment
2017
·
I. K. Malashenkova
, N. A. Khailov
, et al.
·
Neuroscience and Behavioral Physiology
·
7
Efficacy and Safety of Citicoline to Prevent Cognitive Deficiency Progression in First-Degree Relatives of Patients with Alzheimer’s Disease: Prospective Study
2020
·
N. D. Seleznеva
, S. I. Gavrilova
, et al.
·
Psikhiatriya
·
6
PDF
[Clinical experience with agomelatine for the treatment of depression in elderly patients in outpatient practice].
2014
·
S I Gavrilova
, I V Kolykhalov
, et al.
·
PubMed
·
6
Herpesvirus infections and immunological disturbances in patients with different stages of Alzheimer’s disease
2021
·
S. A. Krynskiy
, I. K. Malashenkova
, et al.
·
Problems of Virology
·
5
PDF
Immunological variants of amnestic mild cognitive impairment
2020
·
I.K. Malashenkova
, S.A. Krynskiy
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
5
Detection of effective treatment of amnestic mild cognitive impairement with cereton by testing of lipids markers
2017
·
A. V. Alesenko
, S. I. Gavrilova
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
5
Clinical experience of the use of memantal in patients with moderate and severe Alzheimer’s disease
2016
·
S. I. Gavrilova
, I. V. Kolykhalov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
5
Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia
2024
·
S.I. Gavrilova
, I.V. Kolykhalov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
4
The Effectiveness of Choline Alfoscerate in the Treatment of Patients with Amnestic Mild Cognitive Impairment: A Comparative Prospective Study
2023
·
E. V. Ponomareva
·
Psikhiatriya
·
4
PDF
Immunological Markers of Long-term Effects of Treatment in Patients With Mild Cognitive Impairment
2019
·
S A Krynskiy
, I K Malashenkova
, et al.
·
Medical academic journal
·
4
PDF
The use of acetyl-L-carnitine in gerontological practice
2017
·
E. V. Ponomareva
·
S S Korsakov Journal of Neurology and Psychiatry
·
4
Citicoline in the Treatment of Mild Cognitive Impairment in Blood Relatives of Patients with Alzheimer’s Disease: Immediate and Long-Term Effects of Course Therapy
2021
·
N. D. Seleznеva
, I. F. Roshchina
, et al.
·
Psikhiatriya
·
3
PDF
Clinical and Biological Significance of Neuroinflammation Indicators to Predict the Course of Amnestic Mild Cognitive Impairment
2025
·
E. V. Ponomareva
, S. I. Gavrilova
, et al.
·
Psikhiatriya
·
2
PDF
Russian experience in using a combination of fixed doses of donepezil and memantine in the treatment of Alzheimer’s disease as an observational non-interventional multicenter program
2023
·
I.V. Kolykhalov
, E.A. Mkhitaryan
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
2
A Clinical Trial of the Use of Agomelatine for the Treatment of Depression in Elderly Patients in Out-Patient Conditions
2016
·
S. I. Gavrilova
, I. V. Kolykhalov
, et al.
·
Neuroscience and Behavioral Physiology
·
2
The reduced level of antibodies to acetylcholine receptor alpha 7 fragment in the blood serum of patients with Alzheimer’s disease
2015
·
A. V. Kamynina
, E. V. Ponomareva
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
2
Predicting the Dynamics of Mild Cognitive Impairment According to Immunological Parameters
2023
·
L. V. Androsova
, Ye. V. Ponomaryova
, et al.
·
Psikhiatriya
·
1
PDF
Herpesvirus Infections and Clinical-immunologic Interactions in Patients With Early-onset Alzheimer’s Disease and Late-onset Alzheimer’s Disease
2021
·
I. K. Malashenkova
, D. P. Ogurtsov
, et al.
·
Medical Immunology (Russia)
·
1
PDF
Effectiveness of the DNA double-strand breaks repair system in lymphocytes of patients with cognitive impairments and healthy volunteers
2020
·
Yu.P. Semochkina
, E.Yu. Moskaleva
, et al.
·
Biomeditsinskaya Khimiya
·
1
Show more works
View as search
Works count:
44
Citation count:
144
H-index:
7
I10-index:
2
Year
Topic
Type